CombinatoRx reports revenue boost
14th Nov 2006, 15:49 GMT
A big boost in research and development funding has helped drug developer CombinatoRx Inc. boost fiscal 2006 third-quarter revenue and trim net losses.
CombinatoRx reports revenue boost related news:
- Miracor Diagnostics Reports 3rd Quarter Results — RedOrbit News - Health
- Ex-CA Executive Gets Seven Years — WSJ.com: What's News Technology
- Grammer Reports Strong Revenue, Earnings in First Three Quarters of 2006 — Automotive Headlines
- HemaCare Corporation: Hemacare Reports 18% Increase in Revenue and 52% Increase in Net Income in Third Quarter 2006 — Market Wire - Medical and Healthcare
- Hemacare Reports 18% Increase in Revenue and 52% Increase in Net Income in Third Quarter 2006 — ArriveNet : Health
- El Guapo's Ghost Rambles on about the Red Sox :: — Sports Blogs :: Boston Red Sox Daily Entries
- Alstom 1H profit soars — Boston.com / News
- IRS crackdown: Record revenue — Business and financial news - CNNMoney.com
- IRS enforcement efforts raise record revenue — Latest financial news - CNNMoney.com
- QIAGEN Reports Strong Q3 2006 Results — Financial News News from StratCenter.com
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- Spectrum Pharmaceuticals gets $5M milestone payment, settles with GlaxoSmithKline
- Corautus Genetics chips at Q3 loss
- Spherix hoping to brush its sweet tooth
- Auxilium added to NASDAQ's biotech index
- Alexion gets fast-track FDA review for drug Soliris
- InnoCentive identifies a new CEO
- Digene names new CEO
- Dynamic Health dips into the red
- Sigma-Aldrich elects Paul to board
- CollaGenex to net $43M from stock sale